CCA
LLY icon

Childress Capital Advisors’s Eli Lilly LLY Stock Holding History

Childress Capital Advisors’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.89M Buy
3,245
+201
+7% +$205K 0.64% 34
2026
Q1 		$2.8M Sell
3,044
-1,043
-26% -$1.06M 0.5% 35
2025
Q4 		$4.39M Buy
4,087
+819
+25% +$783K 0.7% 30
2025
Q3 		$2.49M Buy
3,268
+634
+24% +$472K 0.46% 41
2025
Q2 		$2.05M Buy
2,634
+141
+6% +$110K 0.52% 36
2025
Q1 		$2.06M Buy
2,493
+79
+3% +$65.7K 0.6% 31
2024
Q4 		$1.86M Sell
2,414
-31
-1% -$25.7K 0.52% 35
2024
Q3 		$2.17M Buy
2,445
+105
+4% +$94.4K 0.58% 32
2024
Q2 		$2.12M Buy
2,340
+60
+3% +$48K 0.6% 31
2024
Q1 		$1.77M Sell
2,280
-208
-8% -$148K 0.52% 38
2023
Q4 		$1.45M Sell
2,488
-23
-0.9% -$13.4K 0.43% 43
2023
Q3 		$1.35M Buy
2,511
+1,948
+346% +$1M 0.44% 41
2023
Q2 		$264K Sell
563
-511
-48% -$214K 0.11% 64
2023
Q1 		$369K Sell
1,074
-1,713
-61% -$578K 0.16% 59
2022
Q4 		$1.02M Buy
2,787
+62
+2% +$22K 0.34% 53
2022
Q3 		$892K Sell
2,725
-118
-4% -$37.4K 0.35% 54
2022
Q2 		$922K Buy
2,843
+210
+8% +$63K 0.37% 54
2022
Q1 		$755K Buy
2,633
+402
+18% +$103K 0.26% 70
2021
Q4 		$616K Buy
2,231
+57
+3% +$14.4K 0.25% 74
2021
Q3 		$502K Buy
2,174
+113
+5% +$27.9K 0.2% 93
2021
Q2 		$473K Buy
2,061
+340
+20% +$68.3K 0.22% 80
2021
Q1 		$321K Buy
1,721
+1,048
+156% +$205K 0.15% 122
2020
Q4 		$116K Buy
+673
New +$100K 0.07% 135

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Childress Capital Advisors's LLY Position: Q2 2026 in Review

Childress Capital Advisors increased its Eli Lilly (LLY) stake by 6.6% in Q2 2026, buying an estimated $205K and bringing the position to 3,245 shares worth $3.89M. The position accounts for 0.64% of the portfolio, ranked #34.

Childress Capital Advisors first reported a position in LLY in Q4 2020 and has held it in 23 quarters since. The position peaked at $4.39M in Q4 2025. 4,628 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Childress Capital Advisors held 3,245 shares of Eli Lilly worth $3.89M as of Q2 2026.
  • Childress Capital Advisors bought 201 Eli Lilly shares in Q2 2026, an estimated $205K.
  • Eli Lilly made up 0.64% of Childress Capital Advisors's portfolio in Q2 2026, its #34 holding.
  • Childress Capital Advisors first reported a position in Eli Lilly in Q4 2020 and has held it in 23 quarters since.
  • Childress Capital Advisors's Eli Lilly position peaked at $4.39M in Q4 2025.
  • 4,628 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Childress Capital Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.